- Home
- PACS vs SDGR Comparison
PACS vs SDGR Comparison
Compare PACS & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PACS
- SDGR
- Stock Information
- Founded
- PACS 2013
- SDGR 1990
- Country
- PACS United States
- SDGR United States
- Employees
- PACS N/A
- SDGR N/A
- Industry
- PACS
- SDGR Biotechnology: Pharmaceutical Preparations
- Sector
- PACS
- SDGR Health Care
- Exchange
- PACS Nasdaq
- SDGR Nasdaq
- Market Cap
- PACS 1.8B
- SDGR 1.8B
- IPO Year
- PACS 2024
- SDGR 2020
- Fundamental
- Price
- PACS $10.84
- SDGR $18.84
- Analyst Decision
- PACS Strong Buy
- SDGR Buy
- Analyst Count
- PACS 9
- SDGR 7
- Target Price
- PACS $33.22
- SDGR $32.29
- AVG Volume (30 Days)
- PACS 428.3K
- SDGR 876.5K
- Earning Date
- PACS 05-16-2025
- SDGR 04-30-2025
- Dividend Yield
- PACS N/A
- SDGR N/A
- EPS Growth
- PACS 82.80
- SDGR N/A
- EPS
- PACS 0.68
- SDGR N/A
- Revenue
- PACS $3,558,953,000.00
- SDGR $207,539,000.00
- Revenue This Year
- PACS $30.45
- SDGR $24.42
- Revenue Next Year
- PACS $16.80
- SDGR $19.02
- P/E Ratio
- PACS $15.94
- SDGR N/A
- Revenue Growth
- PACS 205.08
- SDGR N/A
- 52 Week Low
- PACS $10.61
- SDGR $16.67
- 52 Week High
- PACS $43.92
- SDGR $29.15
- Technical
- Relative Strength Index (RSI)
- PACS N/A
- SDGR 34.60
- Support Level
- PACS N/A
- SDGR $21.34
- Resistance Level
- PACS N/A
- SDGR $22.85
- Average True Range (ATR)
- PACS 0.00
- SDGR 1.04
- MACD
- PACS 0.00
- SDGR -0.31
- Stochastic Oscillator
- PACS 0.00
- SDGR 8.42
About PACS PACS Group Inc. Common Stock
PACS Group Inc is a post-acute healthcare company primarily focused on delivering high-quality skilled nursing care through a portfolio of independently operated facilities Its is a nursing providers in the United States based on number of facilities, with over 200 post-acute care facilities across nine states serving over 20,000 patients daily. It also provide senior care, assisted living, and independent living options in some of communities.
About SDGR Schrodinger Inc.
Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.